Additionally, the crosstalk between Tph cells and CD11c+CD21− B cells, which is mentioned in this review, might be a novel mechanism by which IgG4-RD develops and those cells are promising therapeutic targets. Here, TPH1 is linked to immunoglobulin G4-related sclerosing disease.